1. Home
  2. LRMR vs PSF Comparison

LRMR vs PSF Comparison

Compare LRMR & PSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

N/A

Current Price

$3.03

Market Cap

253.5M

Sector

Health Care

ML Signal

N/A

Logo Cohen & Steers Select Preferred and Income Fund Inc.

PSF

Cohen & Steers Select Preferred and Income Fund Inc.

N/A

Current Price

$18.39

Market Cap

222.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LRMR
PSF
Founded
N/A
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
253.5M
222.3M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
LRMR
PSF
Price
$3.03
$18.39
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
★ $14.40
N/A
AVG Volume (30 Days)
★ 1.3M
71.9K
Earning Date
11-24-2026
01-01-0001
Dividend Yield
N/A
★ 7.69%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.92
$17.80
52 Week High
$6.42
$20.67

Technical Indicators

Market Signals
Indicator
LRMR
PSF
Relative Strength Index (RSI) 59.82 49.90
Support Level $2.89 $17.81
Resistance Level $4.19 $19.58
Average True Range (ATR) 0.25 0.38
MACD 0.09 -0.01
Stochastic Oscillator 95.93 44.75

Price Performance

Historical Comparison
LRMR
PSF

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Its flagship product candidate, nomlabofusp, is a subcutaneously administered recombinant fusion protein designed to deliver frataxin (FXN) to the mitochondria of patients with Friedreich's ataxia (FA), a rare genetic disease characterized by insufficient production of FXN. The company also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.

About PSF Cohen & Steers Select Preferred and Income Fund Inc.

Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.

Share on Social Networks: